![](https://insights.axtria.com/hubfs/Everest%20Group%20Life%20Sciences%20Digital%20Services%20Specialists.png)
Trending
Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Assessment 2024
We’re proud to have been named a Leader in the Everest Group Life Sciences Digital Services Specialists PEAK Matrix® Report. Everest Group classified ...
![From Chaos to Cohesion-1](https://insights.axtria.com/hs-fs/hubfs/From%20Chaos%20to%20Cohesion-1.jpg?width=234&height=327&name=From%20Chaos%20to%20Cohesion-1.jpg)
HEOR/RWE
![Risk Of Venous Thromboembolism And Major Bleeding In Patients With Acute Medical Illness Receiving Thromboprophylaxis With Enoxaparin](https://insights.axtria.com/hubfs/Risk%20Of%20Venous%20Thromboembolism%20And%20Major%20Bleeding%20In%20Patients%20With%20Acute%20Medical%20Illness%20Receiving%20Thromboprophylaxis%20With%20Enoxaparin.png)
![The Potential Of Real-World Evidence To Complement Basket Trials For Tissue-Agnostic Drugs Targeting Neurotrophic Tropomyosin-Related Kinase Gene Fusions](https://insights.axtria.com/hubfs/Real-World%20Evidence%20For%20Label%20Expansion%20%281%29.webp)
![Targeted Literature Review Of Economic Burden And Modelling Techniques For Duchenne Muscular Dystrophy](https://insights.axtria.com/hubfs/Targeted%20Literature%20Review%20Of%20Economic%20Burden%20And%20Modelling%20Techniques%20For%20Duchenne%20Muscular%20Dystrophy.jpg)
![The Economic Value Of Insulin Glargine 300 U/Ml (GLA-300) In People ≥18 Years Of Age With Type 2 Diabetes Mellitus](https://insights.axtria.com/hubfs/Report-Banner-The-economic-value-of-Insulin-glargine_.jpg)
![Use Of Anti Arrhythmic Drugs Versus Ablation In Atrial Fibrillation (AFib) Report - Clinical And Economic Outcomes](https://insights.axtria.com/hubfs/Axtria-2023/media-wall/Clinical-and-economic-outcomes-400x250.png)